Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:308-312

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greene, E. L.
Right arrow Articles by Egan, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greene, E. L.
Right arrow Articles by Egan, B. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLCYSTEINE
*OLEIC ACID
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2001;37:308.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Signaling Events Mediating the Additive Effects of Oleic Acid and Angiotensin II on Vascular Smooth Muscle Cell Migration

Eddie L. Greene; Gang Lu; Da Zhang; Brent M. Egan

From the Departments of Internal Medicine (E.L.G., B.E.) and Pharmacology (G.L., D.Z., B.E.), Medical University of South Carolina, Charleston.

Correspondence to Eddie L. Greene, MD, Mayo Clinic, Department of Medicine, Nephrology Division, S-24 Eisenberg, 200 First St SW, Rochester, MN 55905. E-mail green.eddie{at}mayo.edu

Obese hypertensive patients with cardiovascular risk factor clustering and increased risk for atherosclerotic disease have increased plasma nonesterified fatty acid levels, including oleic acid (OA), and a more active renin-angiotensin-aldosterone system. Vascular smooth muscle cell (VSMC) migration and proliferation participate in the development of atherosclerotic plaque. OA and angiotensin (Ang) II induce synergistic mitogenic responses in VSMCs through sequential signaling pathways dependent on the activation of protein kinase C (PKC), oxidants (reactive oxygen species, ROS), and extracellular signal-regulated kinase (ERK) activation. We tested the hypotheses that (1) OA and Ang II have additive or synergistic effects on VSMC migration and (2) PKC, ROS, and mitogen-activated protein kinase are critical signaling molecules. OA at 100 µmol/L increases VSMC migration 60±10% over control (P<0.001). Ang II (10-9 mol/L) increases VSMC migration by 62±13% and 73% over control, respectively (P<0.01). Coincubation of cells with OA and Ang II produces a nearly additive increase in VSMC cell migration at 107±20% (P<0.01). Increases in VSMC migration induced by OA alone and combined with Ang II were reduced by PKC inhibition and downregulation. VSMC migration in response to OA alone and with Ang II was also inhibited by N-acetyl-cysteine, MEK inhibition, and ERK antisense. VSMC migration in response to OA alone or combined with Ang II is dependent on activation of PKC, ROS, and ERK activation, further raising the possibility that increased plasma nonesterified fatty acids and an activated renin-angiotensin-aldosterone system in subjects with the risk factor cluster contribute to accelerated atherosclerosis through a PKC, ROS, and ERK-dependent signaling pathway.


Key Words: muscle, smooth, vascular • angiotensin II • protein kinases • signal transduction • oxidative stress




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
W.-S. Wu, R. K. Tsai, C. H. Chang, S. Wang, J.-R. Wu, and Y.-X. Chang
Reactive Oxygen Species Mediated Sustained Activation of Protein Kinase C {alpha} and Extracellular Signal-Regulated Kinase for Migration of Human Hepatoma Cell Hepg2
Mol. Cancer Res., October 1, 2006; 4(10): 747 - 758.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. ten Freyhaus, M. Huntgeburth, K. Wingler, J. Schnitker, A. T. Baumer, M. Vantler, M. M. Bekhite, M. Wartenberg, H. Sauer, and S. Rosenkranz
Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation
Cardiovasc Res, July 15, 2006; 71(2): 331 - 341.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci
Cerebral Arteriolar Structure in Mice Overexpressing Human Renin and Angiotensinogen
Hypertension, January 1, 2003; 41(1): 50 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Askari, M. A. Carroll, M. Capparelli, F. Kramer, R. G. Gerrity, and K. E. Bornfeldt
Oleate and Linoleate Enhance the Growth-promoting Effects of Insulin-like Growth Factor-I through a Phospholipase D-dependent Pathway in Arterial Smooth Muscle Cells
J. Biol. Chem., September 20, 2002; 277(39): 36338 - 36344.
[Abstract] [Full Text] [PDF]